Capsule-Based Dry Powder Inhaler Devices to Dominate Global Market, reaching a Value of US$29.6 Billion by 2031 | FMI Inc.

According to Future Market Insights, the global Dry Powder Inhaler Market is slated to exhibit a CAGR of nearly 4.6% during the forecast period (2021-2031), in terms of volume.

Over 4000,000 Mn units of dry powder inhalers are pegged to be sold across the globe by 2031-end.

Challenges Regarding Varying Characteristics of Dry Powder Inhalers to Pave Opportunities for Medical Device Manufacturers

Regulatory pressures and changes in the drug delivery market have driven the innovation of the dry powder inhaler forward.

Snatch a complimentary report packed with captivating infographics. @
https://www.futuremarketinsights.com/reports/sample/rep-gb-5150

According to the World Health Organization (WHO), nearly 300 Mn people worldwide are affected by asthma, and approximately 240 Mn by chronic obstructive pulmonary disease (COPD).

Over half of these patients combined prefer the use of dry powder inhalers for the treatment of their disease.

These devices have depicted great potential in effective and reliable drug delivery, with novel designs ensuring the possibility to overcome future compliance, cost, and safety challenges.

Some of the essential performance characteristics regarding dry powder inhalers are associated with dose delivery, performances at varying airflows, and fine particle fraction content.

These characteristics may vary concerning powder formulations, creating the need for fine-tuning of the device or powder formulation or both combined for achieving optimal performance.

The requirement is particularly high in micro-dosing dry powder inhalers, which in turn is paving opportunities for medical device manufacturers in terms of innovations and advancements.

Growing adoption of unhealthy lifestyles, increasing geriatric population, and growing air pollution levels fuelling the prevalence of various respiratory disorders are key factors driving the expansion of the global dry powder inhaler market.

In addition, favorable government initiatives being taken across the globe to improve the healthcare infrastructure will further influence the market growth.

However, the fact that dry powder inhalers are not moisture-resistant remains a major challenge for manufacturers, as the medicine loses its properties when it comes in contact with moisture.

The availability of effective alternatives such as nebulizers and electric pumps is expected to restrain the adoption of dry powder inhalers.

Lack of awareness regarding these devices in low-income & underdeveloped countries may further hinder the market growth to a certain extent.

Explore the art of informed decision-making via our methodology. @
https://www.futuremarketinsights.com/request-report-methodology/rep-gb-5150

Key Research Findings from FMI's Report on Dry Powder Inhaler Market

~North America will continue to be the most lucrative region for the growth of the dry powder inhaler market. Dry powder inhaler sales in the region will register the fastest expansion through 2031. Asia-Pacific excluding Japan (APEJ) is expected to be the second largest market for dry powder inhalers.
~Hospital pharmacies will continue to be the leading distribution channel for dry powder inhalers, with sales pegged to surpass 150,000 Mn units by 2031-end.
~Dry powder inhalers will continue to observe the largest application in the treatment of asthma, followed by chronic obstructive pulmonary disease. In addition, sales of dry powder inhalers for application in the treatment of asthma and pulmonary arterial hypertension are slated to exhibit a parallel growth through 2031.

Leading companies in the global dry powder inhaler market are focusing on the development of new-generation products.

These market players are making huge investments in R&D activities associated with novel device architectures, particle engineering, and powder formulations.

Key Market Segments Covered In Dry Powder Inhalers Industry Research

By Product :

~Single Dose Dry Powder Inhalers
~Multi-Dose Dry Powder Inhalers

By Indication :

~Asthma
~Chronic Obstructive Pulmonary Disease (COPD)
~Pulmonary Arterial Hypertension
~Diabetes
~Cystic Fibrosis

By Function :

~Manually Operated Inhaler Devices
~Digitally Operated Inhaler Devices

By End User :

>Institutional Sales
~~Hospital Pharmacies
~~Cancer Research
~~Office-based Speciality Clinics
>Retail Sales
~~Retail Pharmacies
~~Drug Stores
~Mail Order Pharmacies

Have a Look at Trending Reports in the Healthcare Domain:

Hadron Therapy Market: @https://www.futuremarketinsights.com/reports/hadron-therapy-market

Onychomycosis Treatment Market: @ https://www.futuremarketinsights.com/reports/onychomycosis-treatment-market

Single-use Bioreactors Market: @ https://www.futuremarketinsights.com/reports/single-use-bioreactors-market

Contact Us:          

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Read the Complete Research Now: @
https://www.futuremarketinsights.com/reports/dry-powder-inhaler-market

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, Stevie Award - recipient market research organization, and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel, and End Use over the next 10 years.

This release was published on openPR.